ASH
Ashland responds to investor presentation by Ancora Alternatives LLC
Article Summary
BUY- Ashland Inc. (NYSE: ASH) issued a statement in response to an investor presentation by Ancora Alternatives LLC, stating that Ashland remains focused on its growth strategies to execute, globalize, innovate and invest while continuing to improve operational performance and cash generation.
- Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders and welcomes constructive input from shareholders.
- Ashland's Board frequently evaluates Ashland's strategy and value creation opportunities on an ongoing basis, including regular review of operating plan, portfolio priorities and capital policy.
- The Board will continue to make decisions based on the best interest of the company and all of its shareholders.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | -7.2% | 25% | 0.0 ptsDeclining (-7.2%) - NOT a growth stock |
| EPS Growth Next 5Y ? | 13.8% | 25% | 35.0 ptsBelow Screener (13.8%) - Modest outlook |
| Target Price Upside ? | 0.4% | 20% | 10.0 ptsNear/At Target (0.4%) - Target: $64.62 vs Current: $64.87 |
| Gross Margin % ? | 23.5% | 15% | 40.0 ptsModerate (23.5%) - Adequate margins |
| Drawdown from 52-Wk High ? | -1.2% | 15% | 20.0 ptsBarely a Dip (-1.2%) - Near recent highs |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About ASH
- Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally.
- It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments.
- The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals.
- Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.
- The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding.
- Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone.
- It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical.
- The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022.
- Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.